Drug Manufacturers - Specialty & Generic Companies By Current Liabilities
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Liabilities
| Current Liabilities | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | LNTH | Lantheus Holdings | (0.05) | 3.67 | (0.19) | ||
| 2 | BIOA | BioAge Labs, | 0.04 | 5.37 | 0.20 | ||
| 3 | KGET | Kleangas Energy Tech | 0.00 | 0.00 | 0.00 | ||
| 4 | RMTI | Rockwell Medical | (0.04) | 6.89 | (0.27) | ||
| 5 | NSRS | North Springs Resources | 0.00 | 0.00 | 0.00 | ||
| 6 | KALY | Kali Inc | 0.00 | 0.00 | 0.00 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash. Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.